• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Transitions launches Signature VII lenses with Chromea7 technology


This new lens will replace Transitions Signature VI lenses when available in January 2014.

Las Vegas-Transitions Optical, Inc. has launched Transitions Signature VII lenses with Chromea7 technology. Available in early January 2014, Transitions Signature VII lenses will replace Transitions VI lenses in the Transitions family.

Transitions Optical developed Transitions Signature VII lenses to be more responsive in more situations, testing them in more than 200 conditions representing real-life lighting situations including various temperatures, weather conditions, and geographies. Transitions Signature VII lenses use the patented Chromea7 technology, an exclusive dye formulation that allows the lenses to be more reactive to indirect sunlight and reflected sunlight, and become even darker on hot days.

Transitions Signature VII lenses will be offered in gray and brown.

Visit TransitionsSignature.com order a free launch kit, after completing an online quiz on the site. The launch kit will include a product information sheet, frequently asked questions and answers, and technical product notes.

Related Videos
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.